Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 75
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Hum Reprod ; 25(5): 241-256, 2019 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-30865280

RESUMO

Oxidative stress is a major aetiology in many pathologies, including that of male infertility. Recent evidence in somatic cells has linked oxidative stress to the induction of a novel cell death modality termed ferroptosis. However, the induction of this iron-regulated, caspase-independent cell death pathway has never been explored outside of the soma. Ferroptosis is initiated through the inactivation of the lipid repair enzyme glutathione peroxidase 4 (GPX4) and is exacerbated by the activity of arachidonate 15-lipoxygenase (ALOX15), a lipoxygenase enzyme that facilitates lipid degradation. Here, we demonstrate that male germ cells of the mouse exhibit hallmarks of ferroptosis including; a caspase-independent decline in viability following exposure to oxidative stress conditions induced by the electrophile 4-hydroxynonenal or the ferroptosis activators (erastin and RSL3), as well as a reciprocal upregulation of ALOX15 and down regulation of GPX4 protein expression. Moreover, the round spermatid developmental stage may be sensitized to ferroptosis via the action of acyl-CoA synthetase long-chain family member 4 (ACSL4), which modifies membrane lipid composition in a manner favourable to lipid peroxidation. This work provides a clear impetus to explore the contribution of ferroptosis to the demise of germline cells during periods of acute stress in in vivo models.


Assuntos
Ferroptose/efeitos dos fármacos , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos dos fármacos , Oxidantes/farmacologia , Espermátides/efeitos dos fármacos , Aldeídos/antagonistas & inibidores , Aldeídos/farmacologia , Animais , Araquidonato 12-Lipoxigenase/genética , Araquidonato 12-Lipoxigenase/metabolismo , Araquidonato 15-Lipoxigenase/genética , Araquidonato 15-Lipoxigenase/metabolismo , Carbolinas/antagonistas & inibidores , Carbolinas/farmacologia , Membrana Celular/química , Membrana Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Coenzima A Ligases/genética , Coenzima A Ligases/metabolismo , Cicloexilaminas/farmacologia , Desferroxamina/farmacologia , Ferroptose/genética , Humanos , Infertilidade/genética , Masculino , Camundongos , Estresse Oxidativo , Fenilenodiaminas/farmacologia , Fosfolipídeo Hidroperóxido Glutationa Peroxidase/genética , Fosfolipídeo Hidroperóxido Glutationa Peroxidase/metabolismo , Piperazinas/antagonistas & inibidores , Piperazinas/farmacologia , Cultura Primária de Células , Espermátides/citologia , Espermátides/metabolismo , Testículo/citologia , Testículo/efeitos dos fármacos , Testículo/metabolismo
2.
Biochem Pharmacol ; 140: 41-52, 2017 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-28595877

RESUMO

Ferroptosis has recently been identified as a mode of programmed cell death. However, little is yet known about the signaling mechanism. Here, we report that lipoxygenases (LOX) contribute to the regulation of RSL3-induced ferroptosis in acute lymphoblastic leukemia (ALL) cells. We show that the glutathione (GSH) peroxidase 4 (GPX4) inhibitor RSL3 triggers lipid peroxidation, production of reactive oxygen species (ROS) and cell death in ALL cells. All these events are impeded in the presence of Ferrostatin-1 (Fer-1), a small-molecule inhibitor of lipid peroxidation. Also, lipid peroxidation and ROS production precede the induction of cell death, underscoring their contribution to cell death upon exposure to RSL3. Importantly, LOX inhibitors, including the selective 12/15-LOX inhibitor Baicalein and the pan-LOX inhibitor nordihydroguaiaretic acid (NDGA), protect ALL cells from RSL3-stimulated lipid peroxidation, ROS generation and cell death, indicating that LOX contribute to ferroptosis. RSL3 triggers lipid peroxidation and cell death also in FAS-associated Death Domain (FADD)-deficient cells which are resistant to death receptor-induced apoptosis indicating that the induction of ferroptosis may bypass apoptosis resistance. By providing new insights into the molecular regulation of ferroptosis, our study contributes to the development of novel treatment strategies to reactivate programmed cell death in ALL.


Assuntos
Antineoplásicos/farmacologia , Carbolinas/farmacologia , Glutationa Peroxidase/antagonistas & inibidores , Peroxidação de Lipídeos/efeitos dos fármacos , Inibidores de Lipoxigenase/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Antineoplásicos/química , Antioxidantes/farmacologia , Araquidonato 12-Lipoxigenase/química , Araquidonato 12-Lipoxigenase/genética , Araquidonato 12-Lipoxigenase/metabolismo , Araquidonato 15-Lipoxigenase/química , Araquidonato 15-Lipoxigenase/genética , Araquidonato 15-Lipoxigenase/metabolismo , Carbolinas/antagonistas & inibidores , Morte Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Cicloexilaminas/farmacologia , Proteína de Domínio de Morte Associada a Fas/genética , Proteína de Domínio de Morte Associada a Fas/metabolismo , Flavanonas/farmacologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Glutationa Peroxidase/genética , Glutationa Peroxidase/metabolismo , Humanos , Cinética , Masoprocol/farmacologia , Proteínas de Neoplasias/antagonistas & inibidores , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Fenilenodiaminas/farmacologia , Fosfolipídeo Hidroperóxido Glutationa Peroxidase , Leucemia-Linfoma Linfoblástico de Células Precursoras/enzimologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/metabolismo , Espécies Reativas de Oxigênio/antagonistas & inibidores , Espécies Reativas de Oxigênio/metabolismo , alfa-Tocoferol/farmacologia
3.
Curr Drug Deliv ; 7(4): 274-82, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20695838

RESUMO

It has been proposed that endothelial progenitor cells (EPC), originating from the bone marrow contribute to neo-angiogenesis in vivo by forming endothelial cells. Once released in the bloodstream, EPC home at the site of vascular damage where they participate in endothelium regeneration. In this process CXCR4 plays a key role. Recently we demonstrated that a prolonged therapy with phosphodiesterase-5 (PDE5) inhibitors does improve endothelial function and increases circulating EPC, suggesting a role of PDE5 in EPC physiology. Here we tested the expression of PDE5 and CXCR4 on cultured, circulating, and bone marrow resident EPC, and we studied the effect in vivo and in vitro of PDE5 inhibition after administration of a PDE5 inhibitor (tadalafil) on EPC, in term of CXCR4 expression. We documented that in vivo and in vitro EPC express both PDE5 and CXCR4, and that tadalafil administration induced a significant increase in EPC number and the relative CXCR4 expression. This effect is inhibited by selective CXCR4 antagonist. We thus demonstrated that PDE5 inhibition acts on CXCR4 signalling in EPC and we can suppose an involvement of cGMP second messenger system in both EPC release from the bone marrow and EPC-mediated peripheral re-endothelization.


Assuntos
Carbolinas/farmacologia , Inibidores de Fosfodiesterase/farmacologia , Transdução de Sinais/efeitos dos fármacos , Células-Tronco/efeitos dos fármacos , Adulto , Benzilaminas , Carbolinas/antagonistas & inibidores , Células Cultivadas , Ciclamos , Nucleotídeo Cíclico Fosfodiesterase do Tipo 5/metabolismo , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/metabolismo , Compostos Heterocíclicos/farmacologia , Humanos , Masculino , Receptores CXCR4/metabolismo , Células-Tronco/metabolismo , Tadalafila
4.
Shokuhin Eiseigaku Zasshi ; 49(4): 311-5, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18787317

RESUMO

A tadalafil analogue was detected in a dietary supplement marketed for tonic effect, along with hydroxyhomosildenafil and aminotadalafil. The tadalafil analogue was isolated by preparative thin layer chromatography (TLC) and its structure was elucidated using high-performance liquid chromatography (HPLC), liquid chromatography electrospray ionization-mass spectrometry (LC-ESI-MS), Fourier transform-ion cyclotron resonance-mass spectrometry (FT-ICR-MS) and nuclear magnetic resonance (NMR) spectroscopy. The compound was determined to be methyl-1-(1,3-benzodioxol-5-yl)-2-(chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate.


Assuntos
Carbolinas/antagonistas & inibidores , Carbolinas/química , Suplementos Nutricionais/análise , Inibidores de Fosfodiesterase/análise , Cromatografia em Camada Fina , Espectroscopia de Ressonância Magnética , Piperazinas/análise , Purinas/análise , Citrato de Sildenafila , Sulfonas/análise , Tadalafila
5.
Anticancer Res ; 25(1A): 117-20, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15816527

RESUMO

Capsicum fruits are widely consumed as a component of the human diet. Capsaicin is the principle substance responsible for their hot, pungent taste. Heterocyclic amines (HCAs) are formed during cooking of meats and are mutagenic/carcinogenic compounds. In this study, we looked at whether capsaicin showed anti-mutagenic effects toward HCA-induced mutagenesis in Salmonella typhimurium TA98 when incubated with 0.5 mg liver S9 protein from rat, hamster and human. The HCAs used were Trp-P-2, Glu-P-1 and PhIP. Capsaicin, at non-toxic amounts of 0.25 and 0.5 micromole/plate, expressed a dose-dependent inhibition of the mutagenicity of Glu-P-1 and PhIP when they are metabolically activated by rat, hamster and human liver S9 and of Trp-P-2 when activated by rat and hamster liver S9. In contrast, capsaicin enhanced the mutagenicity of Trp-P-2 in TA98 when incubated with human liver S9. The lack of consistency in the anti-mutagenic action of capsaicin toward HCAs is puzzling and currently unresolved.


Assuntos
Antimutagênicos/farmacologia , Capsaicina/farmacologia , Carbolinas/antagonistas & inibidores , Imidazóis/antagonistas & inibidores , Animais , Antimutagênicos/toxicidade , Carbolinas/toxicidade , Cricetinae , Relação Dose-Resposta a Droga , Interações Medicamentosas , Humanos , Imidazóis/toxicidade , Masculino , Mesocricetus , Testes de Mutagenicidade , Mutagênicos/toxicidade , Ratos , Ratos Sprague-Dawley , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/genética
6.
J Agric Food Chem ; 53(6): 2312-5, 2005 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-15769173

RESUMO

The methanol extract from Uncaria sinensis showed a suppressive effect on umu gene expression of the SOS response in Salmonella typhimurium TA1535/pSK1002 against the mutagen 3-amino-1,4-dimethyl-5H-pyrido[4,3b]indole (Trp-P-1), which requires liver metabolizing enzymes. The methanol extract from U. sinensis was re-extracted with hexane, CH2Cl2, BuOH, and water, respectively. CH2Cl2 extract showed a suppressive effect. A suppressive compound 1 in CH2Cl2 extract was isolated by SiO2 column chromatography. Compound 1 was identified as ursolic acid by IR, electron ionization EI-MS, and NMR spectroscopy. Suppressive effects of ursolic acid (1) and its derivatives, methyl ursolate (1M), acetylursolic acid (1A), and methyl acetylursolate (1MA), were determined in the umu test. These compounds suppressed 61.3, 37.7, 71.5, and 37.8% of the Trp-P-1-induced SOS response at a concentration of 0.4 micromol/mL, respectively. The ID50 values of compounds 1 and 1A were 0.17 and 0.20 micromol/mL. In addition, these compounds were assayed with the activated Trp-P-1. Suppressive effects on activated Trp-P-1 were decreased as compared with those of Trp-P-1.


Assuntos
Carbolinas/antagonistas & inibidores , Testes de Mutagenicidade , Resposta SOS em Genética/efeitos dos fármacos , Salmonella typhimurium/genética , Triterpenos/farmacologia , Uncaria/química , Carbolinas/farmacologia , Ácido Ursólico
7.
Life Sci ; 76(1): 85-101, 2004 Nov 19.
Artigo em Inglês | MEDLINE | ID: mdl-15501482

RESUMO

Antigenotoxic properties and the possible mechanisms of water extracts from Cassia tora L. (WECT) treated with different degrees of roasting (unroasted and roasted at 150 and 250 degrees C) were evaluated by the Ames Salmonella/microsome test and the Comet assay. Results indicated that WECT, especially unroasted C. tora (WEUCT), markedly suppressed the mutagenicity of 2-amino-6-methyldipyrido(1,2-a:3':2'-d)imidazole (Glu-P-1) and 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole (Trp-P-1). In the Comet assay performed on human lymphocytes, WECT exhibited significant protective effect on Trp-P-1-mediated DNA damage followed the order of unroasted (55%) > roasted at 150 degrees C (42% ) > roasted at 250 degrees C (29%). Pre-treatment of the lymphocytes with WEUCT resulted in 30% repression of DNA damage. However, no significant effect on excision-repair system was found during DNA damage expression time in post-treatment scheme (p>0.05). WEUCT showed 84% scavenging effect on oxygen free radicals generated in the activation process of mutagen detected by electron paramagentic resonance system. Two possible mechanisms were considered: (1) neutralization the reactive intermediate of Trp-P-1; and (2) protecting cells directly as an antioxidant that scavenge the oxygen radicals from the activation process of mutagen. The individual anthraquinone content in extracts of C. tora was measured by HPLC. Three anthraquinones, chrysophanol, emodin and rhein, have been detected under experimental conditions. The anthraquinone content decreased with increased roasting temperature. Each of these anthraquinones demonstrated significant antigenotoxicity against Trp-P-1 in the Comet assay. In conclusion, our data suggest that the decrease in antigenotoxic potency of roasted C. tora was related to the reduction in their anthraquinones.


Assuntos
Bebidas , Cassia/química , Culinária , Dano ao DNA/efeitos dos fármacos , Análise de Variância , Antraquinonas/química , Antraquinonas/farmacologia , Carbolinas/antagonistas & inibidores , Carbolinas/toxicidade , Cromatografia Líquida de Alta Pressão , Ensaio Cometa , Radicais Livres/metabolismo , Humanos , Imidazóis/antagonistas & inibidores , Imidazóis/toxicidade , Linfócitos/efeitos dos fármacos , Microscopia de Fluorescência , Microssomos , Extratos Vegetais/farmacologia
8.
J Agric Food Chem ; 51(22): 6456-60, 2003 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-14558762

RESUMO

Four prenylated flavanones were isolated from the methanol extract of the flowers of Azadirachta indica (the neem tree) as potent antimutagens against Trp-P-1 (3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole) in the Salmonella typhimurium TA98 assay by activity-guided fractionation. Spectroscopic properties revealed that those compounds were 5,7,4'-trihydroxy-8-prenylflavanone (1), 5,4'-dihydroxy-7-methoxy-8-prenylflavanone (2), 5,7,4'-trihydroxy-3',8-diprenylflavanone (3), and 5,7,4'-trihydroxy-3',5'-diprenylflavanone (4). All isolated compounds were found for the first time in this plant. The antimutagenic IC(50) values of compounds 1-4 were 2.7 +/- 0.1, 3.7 +/- 0.1, 11.1 +/- 0.1, and 18.6 +/- 0.1 microM in the preincubation mixture, respectively. These compounds also similarly inhibited the mutagenicity of Trp-P-2 (3-amino-1-methyl-5H-pyrido[4,3-b]indole) and PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine). All of the compounds 1-4 strongly inhibited ethoxyresorufin O-dealkylation activity of cytochrome P450 1A isoforms, which catalyze N-hydroxylation of heterocyclic amines. However, compounds 1-4 did not show significant inhibition against the direct-acting mutagen NaN(3). Thus, the antimutagenic effect of compounds 1-4 would be mainly based on the inhibition of the enzymatic activation of heterocyclic amines.


Assuntos
Antimutagênicos/isolamento & purificação , Azadirachta/química , Flavanonas/isolamento & purificação , Flores/química , Compostos Heterocíclicos/antagonistas & inibidores , Animais , Carbolinas/antagonistas & inibidores , Citocromo P-450 CYP1A1/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Furilfuramida/farmacologia , Fígado/enzimologia , Espectroscopia de Ressonância Magnética , Masculino , Metanol , Mutagênicos/farmacologia , Nitrogênio/antagonistas & inibidores , Extratos Vegetais/farmacologia , Prenilação de Proteína , Ratos , Ratos Sprague-Dawley
9.
Eur J Pharmacol ; 476(1-2): 55-61, 2003 Aug 22.
Artigo em Inglês | MEDLINE | ID: mdl-12969749

RESUMO

We have previously shown that long-term treatment of rats with antidepressant drugs that affect the activity of noradrenergic and serotonergic neurons by different mechanisms, inhibits the increase in cortical norepinephrine output induced by stress. With the use of microdialysis, we have now evaluated the effects of reboxetine, an antidepressant drug that selectively inhibits norepinephrine reuptake, on the increase in cortical norepinephrine output elicited in rats by exposure to foot-shock stress or by the acute administration of N-methyl-beta-carboline-3-carboxamide (FG 7142) (20 mg/kg, i.p.). Foot-shock stress and FG 7142 each induced a marked increase in the cortical extracellular concentration of norepinephrine (+200 and +90%, respectively) in control rats. Long-term treatment with reboxetine (10 mg/kg, i.p., once a day for 21 days) reduced the effect of foot-shock stress and completely antagonized the effect of FG 7142 on cortical norepinephrine output. Our results suggest that changes in the activity of noradrenergic neurons in the cortex might be relevant to the anxiolytic and antidepressant effects of reboxetine.


Assuntos
Inibidores da Captação Adrenérgica/farmacologia , Antidepressivos/farmacologia , Morfolinas/farmacologia , Norepinefrina/biossíntese , Córtex Pré-Frontal/efeitos dos fármacos , Estresse Fisiológico/metabolismo , Inibidores da Captação Adrenérgica/administração & dosagem , Animais , Antidepressivos/administração & dosagem , Carbolinas/antagonistas & inibidores , Carbolinas/farmacologia , Depressão Química , Relação Dose-Resposta a Droga , Eletrochoque , Antagonistas GABAérgicos/farmacologia , Injeções Intraperitoneais , Masculino , Microdiálise , Morfolinas/administração & dosagem , Córtex Pré-Frontal/metabolismo , Ratos , Ratos Sprague-Dawley , Reboxetina , Fatores de Tempo
10.
J Agric Food Chem ; 50(23): 6923-8, 2002 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-12405798

RESUMO

Honey has been used since ancient times as a flavorful sweetener and for its therapeutic and medicinal effects. Consumers' demand for natural, healthy products has driven renewed interest in honey's health benefits. The commonly encountered food mutagen, Trp-p-1, has been demonstrated to be mutagenic in bacteria and carcinogenic in animals. Chemically, honey is quite complex. Honey is comprised primarily of sugars; however, it contains many other potentially biologically active components, such as antioxidants. Sugars have been reported to display both mutagenic and antimutagenic effects in different systems; antioxidants often display antimutagenic activity. Little information exists about potential antimutagenic effects of honey. Antimutagenicity of honeys from seven different floral sources against Trp-p-1 was tested via the Ames assay and compared to that of a sugar analogue and to individually tested simple sugars. All honeys exhibited significant inhibition of Trp-p-1 mutagenicity; most demonstrated a linear correlation between percentage inhibition and log transformed honey concentration from 10 microg/mL to 20 mg/mL. Each displayed significant degrees of inhibition of mutagenicity above concentrations of 1 mg/mL, with individual variations in degree of effectiveness. Buckwheat honey displayed the greatest inhibition at 1 mg/mL, with slightly less effectiveness at higher concentrations. A sugar analogue demonstrated a pattern of inhibition similar to that of the honeys, with enhanced antimutagenicity at concentrations greater than 1 mg/mL. Glucose and fructose were also similar to honeys and were more antimutagenic than maltose and sucrose.


Assuntos
Antimutagênicos/farmacologia , Carboidratos/farmacologia , Carbolinas/antagonistas & inibidores , Alimentos , Mel/análise , Mutagênicos , Antimutagênicos/análise , Flores/química , Testes de Mutagenicidade , Especificidade da Espécie
11.
Biol Pharm Bull ; 25(4): 520-2, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11995936

RESUMO

Chlorophyllin, a water-soluble derivative of chlorophyll, is known to suppress the mutagenic and carcinogenic action of compounds having polycyclic structures, e.g., heterocyclic amines and aflatoxin B1. Recently, we reported that chlorophyllin fixed on chitosan (chl-chitosan), which is insoluble in water, can efficiently and tightly trap these heterocyclic amines. We have studied whether this adsorption to chl-chitosan can result in an interference with DNA-adduct formation caused by 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), a heterocyclic amine, in CDF1 mice, in which Trp-P-2 had been shown to induce hepatocellular carcinomas. Mice were fed a diet containing Trp-P-2 with or without chl-chitosan. After 3 d of feeding, DNA-adduct formation in liver and lung was examined by 32P-postlabeling analysis. Adducts formed from Trp-P-2 were significantly decreased by the chl-chitosan addition (p<0.05, t-test). These results suggest that the uptake of Trp-P-2 into the mouse was lowered by its adsorption to chl-chitosan, either within the digestive tract or within the food itself. This trapping agent, chl-chitosan, is thus worthy of study for cancer chemoprevention.


Assuntos
Carbolinas/metabolismo , Quitina/análogos & derivados , Quitina/metabolismo , Clorofilídeos/metabolismo , Adutos de DNA/antagonistas & inibidores , Adutos de DNA/metabolismo , Animais , Carbolinas/antagonistas & inibidores , Quitina/farmacologia , Quitosana , Clorofilídeos/farmacologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Camundongos
12.
Jpn J Cancer Res ; 92(8): 848-53, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11509116

RESUMO

We have studied the inhibitory effect of chlorophyllin-chitosan (Chl-Chi) complex, an insoluble form of chlorophyllin, on the DNA adduct formation and mutagenesis by a heterocyclic food mutagen-carcinogen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), in mice carrying the E. coli rpsL gene as a mutagenesis reporter. Upon administration of a diet containing 0.002% or 0.01% Trp-P-2, DNA adducts were formed in various tissues in a dose-dependent manner, with the maximum level observed in the liver. Addition of 3% Chl-Chi to the diet reduced the Trp-P-2 adduct by up to 90%. The rpsL mutant frequencies increased significantly in both the liver and spleen upon administration of a 0.01% Trp-P-2 diet. Addition of Chl-Chi to the diet decreased these induced mutant frequencies to the background level. No harmful effect of Chl-Chi was detected during these experiments. The results show that Chl-Chi may be a candidate chemopreventive agent against the genotoxic action of Trp-P-2, and possibly also other aromatic carcinogens in the diet.


Assuntos
Carbolinas/antagonistas & inibidores , Quitina/farmacologia , Clorofilídeos/farmacologia , Adutos de DNA/efeitos dos fármacos , Mutagênese/efeitos dos fármacos , Proteínas Ribossômicas/genética , Animais , Carbolinas/toxicidade , Carcinoma Hepatocelular/induzido quimicamente , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/prevenção & controle , Quitina/análogos & derivados , Quitosana , Cromatografia em Camada Fina , Dieta , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Proteínas de Escherichia coli , Frequência do Gene , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/prevenção & controle , Camundongos , Camundongos Transgênicos , Testes de Mutagenicidade , Mutagênicos/toxicidade , Proteína S9 Ribossômica
13.
J Neurochem ; 76(4): 1212-20, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11181840

RESUMO

The effects of long-term treatment with imipramine or mirtazapine, two antidepressant drugs with different mechanisms of action, on the response of cortical dopaminergic neurons to foot-shock stress or to the anxiogenic drug FG7142 were evaluated in freely moving rats. As expected, foot shock induced a marked increase (+ 90%) in the extracellular concentration of dopamine in the prefrontal cortex of control rats. Chronic treatment with imipramine or mirtazapine inhibited or prevented, respectively, the effect of foot-shock stress on cortical dopamine output. Whereas acute administration of the anxiogenic drug FG7142 induced a significant increase (+ 60%) in cortical dopamine output in control rats, chronic treatment with imipramine or mirtazapine completely inhibited this effect. In contrast, the administration of a single dose of either antidepressant 40 min before foot shock, had no effect on the response of the cortical dopaminergic innervation to stress. These results show that long-term treatment with imipramine or mirtazapine inhibits the neurochemical changes elicited by stress or an anxiogenic drug with an efficacy similar to that of acute treatment with benzodiazepines. Given that episodes of anxiety or depression are often preceded by stressful events, modulation by antidepressants of the dopaminergic response to stress might be related to the anxiolytic and antidepressant effects of these drugs.


Assuntos
Antidepressivos/administração & dosagem , Ansiedade/metabolismo , Dopamina/metabolismo , Mianserina/análogos & derivados , Córtex Pré-Frontal/efeitos dos fármacos , Córtex Pré-Frontal/metabolismo , Animais , Ansiedade/induzido quimicamente , Carbolinas/antagonistas & inibidores , Relação Dose-Resposta a Droga , Esquema de Medicação , Eletrochoque , Antagonistas GABAérgicos , Imipramina/administração & dosagem , Masculino , Mianserina/administração & dosagem , Microdiálise , Mirtazapina , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
14.
Biosci Biotechnol Biochem ; 65(10): 2358-60, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11758941

RESUMO

A methanolic extract of Oroxylum indicum strongly inhibited the mutagenicity of Trp-P-1 in an Ames test. The major antimutagenic constituent was identified as baicalein with an IC50 value of 2.78+/-0.15 microM. The potent antimutagenicity of the extract was correlated with the high content (3.95+/-0.43%, dry weight) of baicalein. Baicalein acted as a desmutagen since it inhibited the N-hydroxylation of Trp-P-2.


Assuntos
Antimutagênicos/isolamento & purificação , Carbolinas/antagonistas & inibidores , Flavanonas , Flavonoides/isolamento & purificação , Plantas Comestíveis/química , Antimutagênicos/química , Antimutagênicos/farmacologia , Cromatografia Líquida de Alta Pressão , Flavonoides/química , Frutas , Concentração Inibidora 50 , Espectroscopia de Ressonância Magnética , Testes de Mutagenicidade , Mutagênicos , Extratos Vegetais , Espectrofotometria Ultravioleta , Tailândia
15.
Peptides ; 20(12): 1431-6, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10698118

RESUMO

Intracerebroventricular injection of the octadecaneuropeptide ODN in mouse, at doses of 12.5-1000 ng, reduced the percentage of convulsing animals and increased the latency of convulsions elicited by pentylenetetrazol (50 mg/kg, intraperitoneal [i.p.]). ODN also reduced the percentage of mortality induced by pentylenetetrazol (100 mg/kg, i.p.). The COOH-terminal octapeptide fragment of ODN was approximately equally effective but acted more rapidly than ODN to reverse the convulsant effect of pentylenetetrazol. ODN (100 ng, intracerebroventricular [i.c.v.]) increased the convulsion latency and reduced the percentage of animals that convulsed after the administration of the inverse agonist of benzodiazepine receptors DMCM (13 mg/kg, i.p.), whereas the benzodiazepine receptor antagonist flumazenil (1 mg/kg, subcutaneously) abrogated the protective effect of ODN (100 ng, i.c.v.) on pentylenetetrazol-induced convulsions. ODN (100 ng, i.c.v.) also reduced the percentage of DBA/2J mice displaying audiogenic convulsions. In contrast, ODN did not reduce the percentage of mice displaying tonic or clonic convulsions when electrical interauricular stimulations were applied. It is concluded that ODN, or more likely a proteolytic fragment derived from ODN, reduces pentylenetetrazol-induced convulsions through activation of central-type benzodiazepine receptors.


Assuntos
Convulsivantes/antagonistas & inibidores , Convulsivantes/toxicidade , Neuropeptídeos/farmacologia , Pentilenotetrazol/antagonistas & inibidores , Pentilenotetrazol/toxicidade , Convulsões/prevenção & controle , Estimulação Acústica , Sequência de Aminoácidos , Animais , Carbolinas/antagonistas & inibidores , Carbolinas/toxicidade , Inibidor da Ligação a Diazepam , Estimulação Elétrica , Flumazenil/farmacologia , Injeções Intraventriculares , Masculino , Camundongos , Camundongos Endogâmicos DBA , Dados de Sequência Molecular , Neuropeptídeos/administração & dosagem , Neuropeptídeos/química , Fragmentos de Peptídeos/administração & dosagem , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/farmacologia , Receptores de GABA-A/efeitos dos fármacos , Receptores de GABA-A/fisiologia , Convulsões/etiologia , Convulsões/fisiopatologia
16.
Mutat Res ; 400(1-2): 259-69, 1998 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-9685672

RESUMO

Early work from our laboratory has shown that the mutagenicity of heterocyclic amines in Salmonella can be inhibited by hemin and chlorophyllins. We have speculated that the inhibition is a result of complex formation between heterocyclic amines and the pigments, and the speculation has been given a line of experimental evidence. We have now found that ferric-chlorophyllin (Fe-chlorophyllin) can modify the mutagenicity of 3-hydroxyamino-1-methyl-5H-pyrido[4, 3-b]indole (Trp-P-2(NHOH)), a metabolically activated form of 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2). The mutagenicity of Trp-P-2(NHOH) in Salmonella typhimurium TA 98 (without S9) was strongly inhibited by an addition of an equimolar Fe-chlorophyllin in the pre-incubation mixture. Fe-chlorophyllin also inhibited the mutagenicity of 2-hydroxyamino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-P-1(NHOH)). A rapid change in the UV spectrum of a mixture of Trp-P-2(NHOH) and Fe-chlorophyllin was observed. Analysis by high performance liquid chromatography showed that Trp-P-2(NHOH) was converted into 3-nitroso-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2(NO)), the mutagenic potency of which is a quarter of that of Trp-P-2(NHOH). Furthermore, the mutagenicity of Trp-P-2(NO), in turn, was inhibited by Fe-chlorophyllin. We conclude that the suppression of the mutagenicity of Trp-P-2(NHOH) is ascribable to the oxidative function of Fe-chlorophyllin, coupled with its ability to form complex formation with the planar surface of the heterocyclic amine molecules.


Assuntos
Antimutagênicos/farmacologia , Carbolinas/metabolismo , Clorofilídeos/farmacologia , Ferro/farmacologia , Compostos Nitrosos/metabolismo , Aerobiose , Carbolinas/antagonistas & inibidores , Testes de Mutagenicidade , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/genética , Salmonella typhimurium/crescimento & desenvolvimento
17.
Neuropsychopharmacology ; 16(6): 433-7, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9165499

RESUMO

The atypical neuroleptic, clozapine, has been shown to have encouraging, but mixed, effects on prefrontal cortical (PFC) cognitive deficits in schizophrenia, a stress-exacerbated disorder involving dopamine (DA) dysregulation. The current study examined the effects of acute clozapine pretreatment on the spatial working memory deficits induced by the pharmacological stressor, FG7142, in monkeys. Previous research has shown that FG7142 impairs spatial working memory in rats and monkeys through excessive DA receptor stimulation in the PFC (Murphy et al. 1996). Lower clozapine doses (1-3 mg/kg p.o.) reversed the FG7142-induced spatial working memory deficits, whereas doses in the clinical range (e.g., 6 mg/kg, p.o.) did not improve cognitive function in most animals. Clozapine alone produced a dose-related impairment in delayed response performance. These results from nonhuman primates suggest that the clozapine doses commonly used to treat schizophrenia may not be optimal for treating the PFC cognitive deficits associated with this illness.


Assuntos
Antipsicóticos/farmacologia , Depressores do Apetite/farmacologia , Carbolinas/antagonistas & inibidores , Clozapina/farmacologia , Memória de Curto Prazo/efeitos dos fármacos , Percepção Espacial/efeitos dos fármacos , Animais , Carbolinas/farmacologia , Relação Dose-Resposta a Droga , Feminino , Macaca mulatta
18.
Mutat Res ; 371(1-2): 65-71, 1996 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-8950351

RESUMO

Using the Salmonella/microsome assay, the antimutagenic effects of specific components of the extracts from eggplant fruits were investigated. The eggplant fruit juice exhibited an antimutagenic activity against 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) induced mutagenicity. In some of the fractions extracted with several organic solvents (acetone, petroleum ether, ethyl acetate; and methanol), the activity was recognized. No mutagenicity or toxicity for Salmonella typhimurium TA98 in the presence of S9 mixture was observed with any of the extracts. It is suggested that there are multiple components of the activities that exist in the eggplant fruit. We isolated lutein from the 84% methanol (methanol/water, v/v) layer, pheophorbide or chlorophyllide from the 70% methanol layer and tannins containing sugar-moieties from the water layer. Pheophytin a and b, Mg-free derivatives of chlorophyll a and b, were isolated from the petroleum ether layer as possible antimutagens. The pheophytin a with S9 mix inhibited by 30-40% the mutagenicity of Trp-P-2.


Assuntos
Antimutagênicos/farmacologia , Carbolinas/toxicidade , Mutagênicos/toxicidade , Extratos Vegetais/farmacologia , Verduras/química , Carbolinas/antagonistas & inibidores , Extratos Vegetais/isolamento & purificação , Salmonella typhimurium/genética
19.
Biosci Biotechnol Biochem ; 60(7): 1152-5, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8782410

RESUMO

The mutagenicity and desmutagenicity of extracts of soybeans heated at 225 +/- 5 degrees C were investigated by the Ames test. The soybeans were refluxed in water, methanol, or diethylether for 2 h. The aqueous and methanol extracts (2-4 mg/plate) of the heated soybeans exhibited strong desmutagenic activity of 43-92% against heterocyclic amines (Trp-P-1. Glu-P-2, IQ, MeIQx. PhIP), while no mutagenicity was observed. The desmutagenicity of the heated soybean extracts remained even after denaturation by 0.1 N HCl in vitro and absorption by the rat small intestine. The desmutagenic mechanism for heated soybeans was evaluated, and it was verified that the soybean extract exhibited its desmutagenicity by blocking the mutagenicity of activated Trp-P-1, and not by inhibiting the S9 enzyme system.


Assuntos
Antimutagênicos/farmacologia , Glycine max/química , Mutagênicos/toxicidade , Animais , Carbolinas/antagonistas & inibidores , Carbolinas/toxicidade , Técnicas In Vitro , Metanol , Testes de Mutagenicidade , Extratos Vegetais/farmacologia , Ratos , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/genética , Água
20.
J Pharmacol Exp Ther ; 275(2): 784-9, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7473167

RESUMO

The effect of chronic 5 alpha-pregnane-3 alpha-ol-20-one (5 alpha 3 alpha; neurosteroid) treatment was investigated on the gamma-aminobutyric acid (GABA), 5 alpha 3 alpha, and ligands that bind to the benzodiazepine (BZ) site on GABA-induced [36Cl-]influx in intact cultured mammalian cortical neurons. Chronic 5 alpha 3 alpha treatment (1 microM; 5 days) decreased the efficacy of GABA, because its Emax (maximal response) value was decreased, whereas the EC50 (potency) value was not altered. Chronic 5 alpha 3 alpha treatment also decreased the Emax value of BZ agonists like diazepam to potentiate GABA-induced [36Cl-] influx, and decreased the -Emax (maximal inhibitory response) value of inverse agonists like methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3'-carboxylate to inhibit GABA-induced [36Cl-] influx, whereas not altering their EC50/IC50 values. Furthermore, chronic 5 alpha 3 alpha treatment decreased the Emax value of 5 alpha 3 alpha to potentiate GABA-induced [36Cl-] influx, without altering its EC50 value. The decreased efficacy of GABA and 5 alpha 3 alpha were reversed by concomitant exposure of the neurons to R 5135 (3 alpha-hydroxy-16-imino-5 beta-17-androstan-11-one; a competitive GABA antagonist). Taken together, these findings suggest that chronic 5 alpha 3 alpha treatment produces decreased efficacy of GABA, ligands that bind to the BZ site, and neurosteroids at the GABAA-BZ receptor complex. The decreased efficacy is heterologous in nature and involves mediation via the GABAA receptor site.


Assuntos
Córtex Cerebral/efeitos dos fármacos , Canais de Cloreto/antagonistas & inibidores , Moduladores GABAérgicos/farmacologia , Pregnanolona/administração & dosagem , Receptores de GABA/fisiologia , Animais , Carbolinas/antagonistas & inibidores , Células Cultivadas , Feminino , Masculino , Camundongos , Camundongos Endogâmicos C57BL
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...